Viome Life Sciences
Viome Life Sciences is a biotechnology company founded in 2016 focused on preventing, diagnosing, and treating chronic diseases and cancer through a systems biology approach. The company uses advanced metatranscriptomic technology and machine learning to analyze human and microbial gene expression (mRNA) from various biological samples, enabling precision nutrition, diagnostics, and therapeutics. Viome's platform includes over 300,000 samples and provides direct-to-consumer health insights, predictive biomarkers, and precision therapeutics development, including drugs and vaccines. The company holds FDA Breakthrough Device Designation for its oral and throat cancer detection test and collaborates with large pharmaceutical companies. Viome aims to revolutionize healthcare by digitizing human biology and leveraging AI to understand and intervene in chronic diseases at a molecular level.
Viome Life Sciences
Viome Life Sciences is a biotechnology company founded in 2016 focused on preventing, diagnosing, and treating chronic diseases and cancer through a systems biology approach. The company uses advanced metatranscriptomic technology and machine learning to analyze human and microbial gene expression (mRNA) from various biological samples, enabling precision nutrition, diagnostics, and therapeutics. Viome's platform includes over 300,000 samples and provides direct-to-consumer health insights, predictive biomarkers, and precision therapeutics development, including drugs and vaccines. The company holds FDA Breakthrough Device Designation for its oral and throat cancer detection test and collaborates with large pharmaceutical companies. Viome aims to revolutionize healthcare by digitizing human biology and leveraging AI to understand and intervene in chronic diseases at a molecular level.